(BGS) B&G Foods - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NYSE (USA) | Market Cap: 338m USD | Total Return: 14.1% in 12m
Avg Turnover: 8.88M
Qual. Beats: -1
Rev. Trend: -99.3%
Qual. Beats: 0
Warnings
High Debt/EBITDA (7.7) with thin interest coverage (1.2)
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
B&G Foods, Inc. (BGS) is a manufacturer and distributor of shelf-stable and frozen foods, as well as household products, serving the United States, Canada, and Puerto Rico. The company manages a diverse portfolio across four primary segments: Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions. Its brand stable includes recognizable names such as Green Giant, Crisco, Ortega, and Cream of Wheat.
The company operates within the Packaged Foods & Meats sub-industry, a sector characterized by high competition and a focus on brand equity to maintain shelf space. B&G Foods utilizes a multi-channel distribution strategy, selling directly to major retailers and utilizing a network of independent brokers to reach foodservice outlets, warehouse clubs, and mass merchants.
The packaged food business model often relies on inorganic growth through the acquisition of established brands from larger conglomerates to expand market share. Investors may find it useful to examine ValueRay for deeper insights into the companys valuation and historical performance. Founded in 1889 and headquartered in Parsippany, New Jersey, the company has evolved from a regional holdings corporation into a broad-scale North American food provider.
- High debt leverage and interest rates impact net income and dividend sustainability
- Portfolio restructuring through brand divestitures aims to reduce corporate debt load
- Input cost inflation for raw commodities pressures gross margins across food segments
- Shifting consumer preferences toward private labels reduces demand for branded shelf-stable goods
- Integration of frozen vegetable segment performance drives overall revenue and margin volatility
| Net Income: -76.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.35 > 1.0 |
| NWC/Revenue: 24.74% < 20% (prev 28.13%; Δ -3.39% < -1%) |
| CFO/TA 0.03 > 3% & CFO 72.2m > Net Income -76.6m |
| Net Debt (2.01b) to EBITDA (259.8m): 7.73 < 3 |
| Current Ratio: 2.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (80.2m) vs 12m ago 0.67% < -2% |
| Gross Margin: 20.53% > 18% (prev 0.21%; Δ 2.03k% > 0.5%) |
| Asset Turnover: 62.60% > 50% (prev 63.74%; Δ -1.14% > 0%) |
| Interest Coverage Ratio: 1.25 > 6 (EBITDA TTM 259.8m / Interest Expense TTM 148.4m) |
| A: 0.16 (Total Current Assets 673.6m - Total Current Liabilities 225.2m) / Total Assets 2.84b |
| B: 0.14 (Retained Earnings 389.2m / Total Assets 2.84b) |
| C: 0.06 (EBIT TTM 185.4m / Avg Total Assets 2.90b) |
| D: 0.17 (Book Value of Equity 403.4m / Total Liabilities 2.43b) |
| Altman-Z'' = 2.09 = BBB |
| DSRI: 1.07 (Receivables 152.9m/148.0m, Revenue 1.81b/1.88b) |
| GMI: 1.03 (GM 20.53% / 21.24%) |
| AQI: 1.04 (AQ_t 0.66 / AQ_t-1 0.63) |
| SGI: 0.96 (Revenue 1.81b / 1.88b) |
| TATA: -0.05 (NI -76.6m - CFO 72.2m) / TA 2.84b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 4.08 with a total of 1,576,646 shares traded.
Over the past week, the price has changed by -0.24%,
over one month by -24.44%,
over three months by -20.79% and
over the past year by +14.12%.
B&G Foods has received a consensus analysts rating of 2.43. Therefore, it is recommended to sell BGS.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 5.2 | 27.5% |
P/E Forward = 6.9493
P/S = 0.1868
P/B = 0.839
P/EG = 4.5532
Revenue TTM = 1.81b USD
EBIT TTM = 185.4m USD
EBITDA TTM = 259.8m USD
Long Term Debt = 2.00b USD (from longTermDebt, last quarter)
Short Term Debt = 20.1m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (corrected: LT Debt 2.00b + ST Debt 20.1m) + Leases 53.0m
Net Debt = 2.01b USD (calculated: Debt 2.07b - CCE 64.5m)
Enterprise Value = 2.35b USD (338.5m + Debt 2.07b - CCE 64.5m)
Interest Coverage Ratio = 1.25 (Ebit TTM 185.4m / Interest Expense TTM 148.4m)
EV/FCF = 49.84x (Enterprise Value 2.35b / FCF TTM 47.1m)
FCF Yield = 2.01% (FCF TTM 47.1m / Enterprise Value 2.35b)
FCF Margin = 2.60% (FCF TTM 47.1m / Revenue TTM 1.81b)
Net Margin = -4.23% (Net Income TTM -76.6m / Revenue TTM 1.81b)
Gross Margin = 20.53% ((Revenue TTM 1.81b - Cost of Revenue TTM 1.44b) / Revenue TTM)
Gross Margin QoQ = 18.47% (prev 22.03%)
Tobins Q-Ratio = 0.83 (Enterprise Value 2.35b / Total Assets 2.84b)
Interest Expense / Debt = 7.15% (Interest Expense 148.4m / Debt 2.07b)
Taxrate = 21.0% (US default 21%)
NOPAT = 146.5m (EBIT 185.4m * (1 - 21.00%))
Current Ratio = 2.99 (Total Current Assets 673.6m / Total Current Liabilities 225.2m)
Debt / Equity = 5.14 (Debt 2.07b / totalStockholderEquity, last quarter 403.4m)
Debt / EBITDA = 7.73 (Net Debt 2.01b / EBITDA 259.8m)
Debt / FCF = 42.66 (Net Debt 2.01b / FCF TTM 47.1m)
Total Stockholder Equity = 457.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.65% (Net Income -76.6m / Total Assets 2.84b)
RoE = -16.76% (Net Income TTM -76.6m / Total Stockholder Equity 457.2m)
RoCE = 7.54% (EBIT 185.4m / Capital Employed (Equity 457.2m + L.T.Debt 2.00b))
RoIC = 5.71% (NOPAT 146.5m / Invested Capital 2.57b)
WACC = 5.72% (E(338.5m)/V(2.41b) * Re(6.17%) + D(2.07b)/V(2.41b) * Rd(7.15%) * (1-Tc(0.21)))
Discount Rate = 6.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 0.89%
[DCF] Terminal Value 73.10% ; FCFF base≈75.7m ; Y1≈66.4m ; Y5≈53.6m
[DCF] Fair Price = N/A (negative equity: EV 860.6m - Net Debt 2.01b = -1.15b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -1
Revenue Correlation: -99.33 | Revenue CAGR: -6.08% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.06 | Chg30d=-33.41% | Revisions=-50% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.18 | Chg30d=+1.57% | Revisions=-14% | Analysts=5
EPS current Year (2026-12-31): EPS=0.60 | Chg30d=-3.42% | Revisions=-25% | GrowthEPS=+18.4% | GrowthRev=-5.2%
EPS next Year (2027-12-31): EPS=0.65 | Chg30d=-3.69% | Revisions=-33% | GrowthEPS=+8.1% | GrowthRev=+1.3%
[Analyst] Revisions Ratio: -50%